Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI database
MetadataShow full item record
Udovin, Lucas Daniel
Introduction: We explored the potential clinical effects of angiotensin-II AT1 receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) in patients from the Parkinson's Progress Marker Initiative (PPMI) study database. Methods: We included 423 newly diagnosed PD patients, free from antiparkinsonian treatment, from the PPMI. We compared the proportion of patients starting on L-DOPA during the first year of follow-up, and the changes in MDS-UPDRS total score and sub-scores during the first five follow-up years for patients exposed or not to ARBs or ACEIs. Results: Treatment with ARBs did not affect the proportion of patients on L-DOPA during the first year (adjusted OR, 95% CI = 0.26, 0.03–2.18, N.S.) while reduced MDS-UPDRS total score (0.85, 0.76–0.95, p < 0.01). Patients treated with ACEIs experienced no changes in either measure. Conclusions: These results show potential signals for a beneficial effect with ARBs. Further clinical trials are warranted.
Showing items related by title, author, creator and subject.
Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson’s disease (2020) Perez-Lloret S.; Otero-Losada M.; Toblli J.E.; Capani F. (Taylor and Francis Ltd, 2017)
ArticleOtero-Losada, Matilde; Kobiec, Tamara; Udovin, Lucas Daniel; Chevalier, Guenson; Quarracino, Cecilia; Menéndez Maissonave, Camila; Bordet, Sofia; Capani, Francisco; Perez-Lloret, Santiago (Frontiers Media S.A., 2020-09-11)
The Renin–Angiotensin System Modulates Dopaminergic Neurotransmission: A New Player on the Scene (2021) Kobiec, Tamara; Otero-Losada, Matilde; Chevalier, Guenson; Udovin, Lucas Daniel; Bordet, Sofía; Menéndez-Maissonave, Camila; Capani, Francisco; Perez-Lloret, Santiago (Frontiers Media S.A., 2021-04-22)Parkinson’s disease (PD) is an extrapyramidal disorder characterized by neuronal degeneration in several regions of the peripheral and central nervous systems. It is the second most frequent neurodegenerative disease after ...